Wellington Management Group LLP 13D and 13G filings for Dicerna Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-04 11:40 am Purchase | 2020-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | Wellington Management Group LLP | 4,317,623 5.750% | 3,648,932 (+545.68%) | Filing |